Patent Partner to Teach Lawyers About Protecting Software in Smartwatches and Smartphones Used as Medical Devices

August 28, 2021

Ryan Phelan, a partner at Marshall Gerstein, will discuss Software as a Medical Device on a panel for an online continuing legal education program next month. Just as the use of smartwatches and smartphones is growing—from tracking personal exercise to displaying MRI scans—so are legal questions about their software’s intellectual property rights. The event will be hosted by Strafford, which produces online continuing legal education (CLE) programs.

Date and Time: Tuesday, September 28, from 1 p.m. to 2 p.m. EDT.
Event Name: Protecting Software as a Medical Device

This CLE webinar will guide counsel for companies in the medical device industry on protecting software as a medical device (SaMD). The panel will discuss the FDA rules regulating SaMD and how to leverage IP law to protect SaMD. With new technologies and products introduced every day, companies and counsel want maximum protection for SaMD. Patent, design patent, trade secrets, and other forms of IP are increasingly crucial to SaMD innovators due to the significant investments needed to withstand FDA scrutiny under the guidelines. However, what is patent eligible in the context of software-related inventions is not always clear.

Ryan will speak alongside:

  • Maia H. Harris, partner at Troutman Pepper
  • Scott P. McBride, shareholder at McAndrews Held & Malloy

Ryan is a registered patent attorney who counsels and works with clients in all areas of intellectual property (IP), with a focus on patents. With a MBA from Northwestern’s Kellogg School of Management, Ryan works with clients to achieve their business objectives, including developing and protecting their innovations and businesses with IP.

Offsite Notice

By clicking “Proceed” below, you will be opening a new browser window and leaving our website.